When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

With proper screening, vaccination, and awareness, we can significantly reduce cervical cancer cases. It is crucial to ...

The cost of diagnosis of cancer, which can go up to Rs 50,000-60,000 is not included in the health insurance policies ...

IT’S a disease that only affects old men. Wrong. You won’t die of it, you die with it. Wrong again! Prostate cancer is the most common cancer in England, overtaking breast cancer for the first ...

A pregnant twenty two year old Angella Kagoya, a survivor of cervical cancer in Mayuge District, Uganda, hangs clothes on a ...

The Indonesian Government has prepared a National Action Plan to handle four priority cancers, including eradicating cervical ...

Recent research highlights the role of the vaginal microbiome in preventing cervical cancer. Probiotics aid in maintaining a ...

Abstract: Early detection and diagnosis of cervical lesions is crucial for mitigating cervical cancer. Because of limited access to ... while integrating inter-class information within both early and ...